Sign inGet started

BANSAL AJAY

Insider CIK 1236922 · ONTX Chief Financial Officer · GNOM SVP & Chief Financial Officer · VRAY Chief Financial Officer · UROV See Remarks

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
UROV Urovant Sciences Ltd. D To issuer deriv2021-03-292021-03-31140,000— $00SEC↗
UROV Urovant Sciences Ltd. D To issuer2021-03-292021-03-31115,222— $00SEC↗
UROV Urovant Sciences Ltd. D To issuer2021-03-292021-03-3124,876— $00SEC↗
UROV Urovant Sciences Ltd. A Award2020-05-012020-05-0463,659— $0138,659SEC↗
UROV Urovant Sciences Ltd. A Award deriv2019-11-052019-11-05140,000— $0140,000SEC↗
UROV Urovant Sciences Ltd. A Award2019-11-052019-11-0575,000— $075,000SEC↗
VRAY ViewRay, Inc. X Exercise deriv2019-07-252019-07-2912,519$0.13 $1.6K0SEC↗
VRAY ViewRay, Inc. X Exercise2019-07-252019-07-2912,519$3.17 $39.7K103,284SEC↗
VRAY ViewRay, Inc. F Tax w/h2019-07-252019-07-294,408$9.00 $39.7K98,876SEC↗
VRAY ViewRay, Inc. A Award deriv2019-03-012019-03-0536,038— $036,038SEC↗
VRAY ViewRay, Inc. A Award2019-03-012019-03-0520,661— $090,765SEC↗
VRAY ViewRay, Inc. A Award deriv2018-04-162018-04-18110,000— $0110,000SEC↗
VRAY ViewRay, Inc. A Award deriv2017-02-182017-02-2350,000— $050,000SEC↗
VRAY ViewRay, Inc. A Award deriv2017-01-232017-01-25103,537— $0103,537SEC↗
VRAY ViewRay, Inc. P Buy deriv2017-01-182017-01-2012,519$0.13 $1.6K12,519SEC↗
VRAY ViewRay, Inc. P Buy2017-01-182017-01-2062,597$3.17 $198.4K70,104SEC↗
VRAY ViewRay, Inc. A Award2016-12-152016-12-197,507— $07,507SEC↗
VRAY ViewRay, Inc. A Award deriv2016-09-132016-09-1559,832— $059,832SEC↗
VRAY ViewRay, Inc. A Award deriv2016-06-142016-06-16550,000— $0550,000SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2016-01-262016-01-2869,984— $069,984SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2015-09-252015-10-0132,500— $032,500SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2015-04-162015-04-2032,500— $032,500SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2014-12-182014-12-2265,000— $065,000SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2013-12-202013-12-2465,000— $065,000SEC↗
ONTX Onconova Therapeutics, Inc C Conversion deriv2013-07-302013-08-0128,181— $00SEC↗
ONTX Onconova Therapeutics, Inc C Conversion2013-07-302013-08-0123,785— $043,846SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2013-07-252013-07-295,000— $05,000SEC↗
ONTX Onconova Therapeutics, Inc A Award deriv2013-07-252013-07-2940,000— $040,000SEC↗
GNOM COMPLETE GENOMICS INC D To issuer deriv2013-03-182013-03-1850,000$0.14 $7.0K0SEC↗
GNOM COMPLETE GENOMICS INC D To issuer deriv2013-03-182013-03-18128,000$0.46 $58.9K0SEC↗
GNOM COMPLETE GENOMICS INC D To issuer2013-03-142013-03-181,696$3.15 $5.3K0SEC↗
GNOM COMPLETE GENOMICS INC A Award deriv2012-04-022012-04-0450,000— $050,000SEC↗
GNOM COMPLETE GENOMICS INC A Award deriv2011-04-112012-02-1470,000— $070,000SEC↗